Literature DB >> 29414545

Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey.

Jonathan D Campbell1, Melanie D Whittington2, Chong H Kim3, Gina R VanderVeen4, Kelly G Knupp5, Arnold Gammaitoni6.   

Abstract

OBJECTIVE: The objective of this study was to describe and quantify the impact of caring for a child with Dravet syndrome (DS) on caregivers.
METHODS: We surveyed DS caregivers at a single institution with a large population of patient with DS. Survey domains included time spent/difficulty performing caregiving tasks (Oberst Caregiving Burden Scale, OCBS); caregiver health-related quality of life (EuroQoL 5D-5L, EQ-5D); and work/activity impairment (Work Productivity and Activity Impairment questionnaire, WPAI). Modified National Health Interview Survey (NHIS) questions were included to assess logistical challenges associated with coordinating medical care.
RESULTS: Thirty-four primary caregivers responded, and 30/34 respondents completed the survey. From OCBS, providing transportation, personal care, and additional household tasks required the greatest caregiver time commitment; arranging for child care, communication, and managing behavioral problems presented the greatest difficulty. EuroQoL 5D-5L domains with the greatest impact on caregivers (0=none, 5=unable/extreme) were anxiety/depression (70% of respondents≥slight problems, 34%≥moderate) and discomfort/pain (57% of respondents≥slight problems, 23%≥moderate). The mean EQ-5D general health visual analogue scale (VAS) score (0=death; 100=perfect health) was 67 (range, 11-94). Respondents who scored <65 were two- to fourfold more likely to report ≥moderate time spent and difficulty managing child behavior problems and assisting with walking, suggesting that children with DS with high degrees of motor or neurodevelopmental problems have an especially high impact on caregiver health. On the WPAI, 26% of caregivers missed >1day of work in the previous week, with 43% reporting substantial impact (≥6, scale=1-10) on work productivity; 65% reported switching jobs, quitting jobs, or losing a job due to caregiving responsibilities. National Health Interview Survey responses indicated logistical burdens beyond the home; 50% of caregivers made ≥10 outpatient visits in the past year with their child with DS.
CONCLUSIONS: Caring for patients with DS exerts physical, emotional, and time burdens on caregivers. Supportive services for DS families are identified to highlight an unmet need for DS treatments.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caregiver burden; Dravet syndrome; EuroQoL 5D-5L; Oberst Caregiving Burden Scale; Supportive services

Mesh:

Year:  2018        PMID: 29414545     DOI: 10.1016/j.yebeh.2018.01.003

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  Spillover Effects on Caregivers' and Family Members' Utility: A Systematic Review of the Literature.

Authors:  Eve Wittenberg; Lyndon P James; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

Review 2.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

3.  Coping with Wolf-Hirschhorn syndrome: quality of life and psychosocial features of family carers.

Authors:  Sarah Berrocoso; Imanol Amayra; Esther Lázaro; Oscar Martínez; Juan Francisco López-Paz; Maitane García; Manuel Pérez; Mohammad Al-Rashaida; Alicia Aurora Rodríguez; Paula Maria Luna; Paula Pérez-Núñez; Raquel Blanco; Julián Nevado
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

4.  Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".

Authors:  Kelly Hollenack; Jade Marshall
Journal:  Pharmacoeconomics       Date:  2021-03-06       Impact factor: 4.981

5.  Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms.

Authors:  Chia-Hsuan Huang; Pi-Lien Hung; Pi-Chuan Fan; Kuang-Lin Lin; Ting-Rong Hsu; I-Jun Chou; Che-Sheng Ho; I-Ching Chou; Wei-Sheng Lin; Inn-Chi Lee; Hueng-Chuen Fan; Shyi-Jou Chen; Jao-Shwann Liang; Yi-Fang Tu; Tung-Ming Chang; Su-Ching Hu; Lee-Chin Wong; Kun-Long Hung; Wang-Tso Lee
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

6.  Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.

Authors:  Boudewijn Gunning; Maria Mazurkiewicz-Bełdzińska; Richard F M Chin; Hari Bhathal; Charlotte Nortvedt; Eduardo Dunayevich; Daniel Checketts
Journal:  Acta Neurol Scand       Date:  2020-10-22       Impact factor: 3.209

7.  Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.

Authors:  Wyman W Lai; Bradley S Galer; Pierre C Wong; Gail Farfel; Milka Pringsheim; Martin G Keane; Anupam Agarwal
Journal:  Epilepsia       Date:  2020-08-18       Impact factor: 5.864

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.